BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Pustenko A, Balašova A, Nocentini A, Supuran CT, Žalubovskis R. 3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 2023;38:216-224. [DOI: 10.1080/14756366.2022.2143496] [Reference Citation Analysis]
2 Ivanova J, Abdoli M, Nocentini A, Žalubovskis R, Supuran CT. 1,2,3-Benzoxathiazine-2,2-dioxides – effective inhibitors of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 2023;38:225-238. [DOI: 10.1080/14756366.2022.2142787] [Reference Citation Analysis]
3 De Luca V, Carginale V, Supuran CT, Capasso C. The gram-negative bacterium Escherichia coli as a model for testing the effect of carbonic anhydrase inhibition on bacterial growth. J Enzyme Inhib Med Chem 2022;37:2092-8. [PMID: 35899716 DOI: 10.1080/14756366.2022.2101644] [Reference Citation Analysis]
4 Supuran CT. Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities. J Enzyme Inhib Med Chem 2022;37:2478-88. [PMID: 36073149 DOI: 10.1080/14756366.2022.2121393] [Reference Citation Analysis]
5 Bonardi A, Parkkila S, Supuran CT. Inhibition studies of the protozoan α-carbonic anhydrase from Trypanosoma cruzi with phenols. J Enzyme Inhib Med Chem 2022;37:2417-22. [PMID: 36065959 DOI: 10.1080/14756366.2022.2119965] [Reference Citation Analysis]
6 Angeli A, Urbański LJ, Capasso C, Parkkila S, Supuran CT. Activation studies with amino acids and amines of a β-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri previously annotated as Staphylococcus aureus (SauBCA) carbonic anhydrase. J Enzyme Inhib Med Chem 2022;37:2786-92. [PMID: 36210544 DOI: 10.1080/14756366.2022.2131780] [Reference Citation Analysis]
7 Krymov SK, Scherbakov AM, Dezhenkova LG, Salnikova DI, Solov’eva SE, Sorokin DV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance. Pharmaceuticals 2022;15:1453. [DOI: 10.3390/ph15121453] [Reference Citation Analysis]
8 Supuran CT. Carbonic Anhydrase Inhibitors from Marine Natural Products. Marine Drugs 2022;20:721. [DOI: 10.3390/md20110721] [Reference Citation Analysis]
9 Zhou W, Wang C, Liu Z, Gou S. Hypoxia-Activated Prodrugs with Dual COX-2/CA Inhibitory Effects on Attenuating Cardiac Inflammation under Hypoxia. J Med Chem 2022. [PMID: 36170566 DOI: 10.1021/acs.jmedchem.2c01355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Beatriz Vermelho A, Rodrigues GC, Nocentini A, Mansoldo FRP, Supuran CT. Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs? Expert Opin Drug Discov 2022;:1-12. [PMID: 36039500 DOI: 10.1080/17460441.2022.2117295] [Reference Citation Analysis]
11 Matos MJ, Santana L, Uriarte E, Borges F. Thiocoumarins: From the Synthesis to the Biological Applications. Molecules 2022;27:4901. [DOI: 10.3390/molecules27154901] [Reference Citation Analysis]
12 Pontecorvi V, Mori M, Picarazzi F, Zara S, Carradori S, Cataldi A, Angeli A, Berrino E, Chimenti P, Ciogli A, Secci D, Guglielmi P, Supuran CT. Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies. IJMS 2022;23:7950. [DOI: 10.3390/ijms23147950] [Reference Citation Analysis]
13 Arrighi G, Puerta A, Petrini A, Hicke FJ, Nocentini A, Fernandes MX, Padrón JM, Supuran CT, Fernández-bolaños JG, López Ó. Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. IJMS 2022;23:7685. [DOI: 10.3390/ijms23147685] [Reference Citation Analysis]
14 Peña L, Jiménez C, Arancibia R, Angeli A, Supuran CT. Heterobimetallic complexes containing organometallic acylhydrazone ligands as potential inhibitors of human carbonic anhydrases. Journal of Inorganic Biochemistry 2022;232:111814. [DOI: 10.1016/j.jinorgbio.2022.111814] [Reference Citation Analysis]
15 Giovannuzzi S, Capasso C, Nocentini A, Supuran CT. Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII. Molecules 2022;27:4076. [DOI: 10.3390/molecules27134076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Aspatwar A, Barker H, Aisala H, Zueva K, Kuuslahti M, Tolvanen M, Primmer CR, Lumme J, Bonardi A, Tripathi A, Parkkila S, Supuran CT. Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris. J Enzyme Inhib Med Chem 2022;37:1577-86. [PMID: 35637617 DOI: 10.1080/14756366.2022.2080818] [Reference Citation Analysis]
17 Abdoli M, Giovannuzzi S, Supuran CT, Žalubovskis R. 4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:1568-76. [DOI: 10.1080/14756366.2022.2080816] [Reference Citation Analysis]
18 Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Kciuk M, Gielecińska A, Mujwar S, Mojzych M, Marciniak B, Drozda R, Kontek R. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J Enzyme Inhib Med Chem 2022;37:1278-98. [PMID: 35506234 DOI: 10.1080/14756366.2022.2052868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Kalinin S, Kovalenko A, Valtari A, Nocentini A, Gureev M, Urtti A, Korsakov M, Supuran CT, Krasavin M. 5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery. J Enzyme Inhib Med Chem 2022;37:1005-11. [PMID: 35350949 DOI: 10.1080/14756366.2022.2056733] [Reference Citation Analysis]
21 Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, Mckenna R, Nocentini A, Supuran CT. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:930-9. [DOI: 10.1080/14756366.2022.2053526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Khatua S, Taraphder S. In the footsteps of an inhibitor unbinding from the active site of human carbonic anhydrase II. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2048075] [Reference Citation Analysis]
23 Onyılmaz M, Koca M, Bonardi A, Degirmenci M, Supuran CT. Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:743-8. [DOI: 10.1080/14756366.2022.2041630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Giovannuzzi S, De Luca V, Nocentini A, Capasso C, Supuran CT. Coumarins inhibit η-class carbonic anhydrase from Plasmodium falciparum. J Enzyme Inhib Med Chem 2022;37:680-5. [PMID: 35139744 DOI: 10.1080/14756366.2022.2036986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mori M, Supuran CT. Acipimox inhibits human carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:672-9. [PMID: 35139721 DOI: 10.1080/14756366.2022.2037579] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Giovannuzzi S, Hewitt CS, Nocentini A, Capasso C, Costantino G, Flaherty DP, Supuran CT. Inhibition studies of bacterial α-carbonic anhydrases with phenols. J Enzyme Inhib Med Chem 2022;37:666-71. [PMID: 35139743 DOI: 10.1080/14756366.2022.2038592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Krymov SK, Scherbakov AM, Salnikova DI, Sorokin DV, Dezhenkova LG, Ivanov IV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold. Eur J Med Chem 2022;228:113997. [PMID: 34902732 DOI: 10.1016/j.ejmech.2021.113997] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
28 Giovannuzzi S, D'Ambrosio M, Luceri C, Osman SM, Pallecchi M, Bartolucci G, Nocentini A, Supuran CT. Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms. Int J Mol Sci 2021;23:461. [PMID: 35008884 DOI: 10.3390/ijms23010461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Petreni A, Osman SM, Alasmary FA, Almutairi TM, Nocentini A, Supuran CT. Binding site comparison for coumarin inhibitors and amine/amino acid activators of human carbonic anhydrases. Eur J Med Chem 2021;226:113875. [PMID: 34634741 DOI: 10.1016/j.ejmech.2021.113875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
30 Supuran CT. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2021;:1-12. [PMID: 34865569 DOI: 10.1080/13543784.2021.2014813] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 16.0] [Reference Citation Analysis]
31 Wang J, Zhang Y, Nie W, Luo Y, Deng L. Computational anti-COVID-19 drug design: progress and challenges. Brief Bioinform 2021:bbab484. [PMID: 34850817 DOI: 10.1093/bib/bbab484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 De Luca V, Angeli A, Mazzone V, Adelfio C, Carta F, Selleri S, Carginale V, Scaloni A, Supuran CT, Capasso C. Inhibitory Effects of Sulfonamide Derivatives on the β-Carbonic Anhydrase (MpaCA) from Malassezia pachydermatis, a Commensal, Pathogenic Fungus Present in Domestic Animals. Int J Mol Sci 2021;22:12601. [PMID: 34830480 DOI: 10.3390/ijms222212601] [Reference Citation Analysis]
33 Ciccone L, Cerri C, Nencetti S, Orlandini E. Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives. Molecules 2021;26:6380. [PMID: 34770789 DOI: 10.3390/molecules26216380] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
34 Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem 2021;13:1935-7. [PMID: 34498952 DOI: 10.4155/fmc-2021-0222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
35 Supuran CT, Nocentini A, Yakubova E, Savchuk N, Kalinin S, Krasavin M. Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms. J Enzyme Inhib Med Chem 2021;36:1056-60. [PMID: 34000969 DOI: 10.1080/14756366.2021.1927007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 De Luca V, Petreni A, Carginale V, Scaloni A, Supuran CT, Capasso C. Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:1000-6. [PMID: 33980103 DOI: 10.1080/14756366.2021.1919891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Baglini E, Ravichandran R, Berrino E, Salerno S, Barresi E, Marini AM, Viviano M, Castellano S, Da Settimo F, Supuran CT, Cosconati S, Taliani S. Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies. J Enzyme Inhib Med Chem 2021;36:1874-83. [PMID: 34340614 DOI: 10.1080/14756366.2021.1956913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Supuran CT. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. J Enzyme Inhib Med Chem 2021;36:1702-14. [PMID: 34325588 DOI: 10.1080/14756366.2021.1945049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
39 Sethi KK, Mishra KMA, Verma SM, Vullo D, Carta F, Supuran CT. Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties. Pharmaceuticals (Basel) 2021;14:693. [PMID: 34358123 DOI: 10.3390/ph14070693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Temiz E, Koyuncu I, Durgun M, Caglayan M, Gonel A, Güler EM, Kocyigit A, Supuran CT. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells. Int J Mol Sci 2021;22:6098. [PMID: 34198834 DOI: 10.3390/ijms22116098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
41 Urbanski LJ, Vullo D, Parkkila S, Supuran CT. An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus. J Enzyme Inhib Med Chem 2021;36:1088-92. [PMID: 34056990 DOI: 10.1080/14756366.2021.1931863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Dettori I, Fusco I, Bulli I, Gaviano L, Coppi E, Cherchi F, Venturini M, Di Cesare Mannelli L, Ghelardini C, Nocentini A, Supuran CT, Pugliese AM, Pedata F. Protective effects of carbonic anhydrase inhibition in brain ischaemia in vitro and in vivo models. J Enzyme Inhib Med Chem 2021;36:964-76. [PMID: 34056989 DOI: 10.1080/14756366.2021.1907575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
43 Nocentini A, Hewitt CS, Mastrolorenzo MD, Flaherty DP, Supuran CT. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhib Med Chem 2021;36:1061-6. [PMID: 34030562 DOI: 10.1080/14756366.2021.1929202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135:1233-49. [PMID: 34013961 DOI: 10.1042/CS20210040] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 45.0] [Reference Citation Analysis]
45 Mueller SL, Chrysanthopoulos PK, Halili MA, Hepburn C, Nebl T, Supuran CT, Nocentini A, Peat TS, Poulsen SA. The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors-A Spin-Off Discovery from Fragment Screening. Molecules 2021;26:3010. [PMID: 34070212 DOI: 10.3390/molecules26103010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Nocentini A, Capasso C, Supuran CT. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present). Expert Opin Ther Pat 2021;:1-10. [PMID: 33909515 DOI: 10.1080/13543776.2021.1923694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Angeli A, Kartsev V, Petrou A, Pinteala M, Brovarets V, Slyvchuk S, Pilyo S, Geronikaki A, Supuran CT. Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties. Int J Mol Sci 2021;22:5082. [PMID: 34064890 DOI: 10.3390/ijms22105082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bulli I, Dettori I, Coppi E, Cherchi F, Venturini M, Di Cesare Mannelli L, Ghelardini C, Nocentini A, Supuran CT, Pugliese AM, Pedata F. Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents. Int J Mol Sci 2021;22:5029. [PMID: 34068564 DOI: 10.3390/ijms22095029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Peerzada MN, Hamel E, Bai R, Supuran CT, Azam A. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development. Pharmacol Ther 2021;225:107860. [PMID: 33895188 DOI: 10.1016/j.pharmthera.2021.107860] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
50 Supuran CT. Coronaviruses. Expert Opin Ther Pat 2021;31:291-4. [PMID: 33685360 DOI: 10.1080/13543776.2021.1901402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 Supuran CT. Carbonic Anhydrase Inhibitors: Designing Isozyme-Specific Inhibitors as Therapeutic Agents. Progress in Drug Research 2021. [DOI: 10.1007/978-3-030-79511-5_10] [Reference Citation Analysis]